Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6802167 | Journal of Substance Abuse Treatment | 2016 | 5 Pages |
Abstract
Two in five persons seeking detoxification for an opioid use disorder used a BZD in the prior month. Anxiety was the most common reason patients reported using a benzodiazepine, but they also reported using BZDs to enhance a 'high' and manage opioid withdrawal. Evidence-based discussions about the risks of combining BZDs and opioids, and alternatives to BZDs should be a high priority in detoxification settings.
Related Topics
Life Sciences
Neuroscience
Biological Psychiatry
Authors
Michael D. M.D., Mitika M.D., M.P.H., Bradley J. Ph.D., Anna M.D., Genie L. M.D.,